2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer
申请人:Chamberlain Stanley Dawes
公开号:US20100204196A1
公开(公告)日:2010-08-12
Novel pyrrolopyrimidines as shown in formula (I):
and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.
式(I)所示的新型
吡咯吡咪啉及其药学上可接受的衍
生物。这些化合物在抑制IGF-1R方面是有用的。